Combination of cardiac magnetic resonance with troponin to facilitate the earliest reversible stage of diagnosis and intervention of cancer therapy-related cardiac dysfunction: a description of three cases.
作者信息
Zhang Yong, Lyu An-Qi, Zhang Fang, Zhao Ling-Di, Zhang Hong-Kai, Wang Zi-Bing, Li Tie-Peng, Wang Wen-Jing, Li Fang-Hui, You Hong-Qin, Gao Quan-Li, Qu Jin-Rong
机构信息
Department of Immunotherapy, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Department of Radiology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
出版信息
Quant Imaging Med Surg. 2024 Oct 1;14(10):7717-7722. doi: 10.21037/qims-24-910. Epub 2024 Sep 13.
Abstract
摘要
相似文献
1
Combination of cardiac magnetic resonance with troponin to facilitate the earliest reversible stage of diagnosis and intervention of cancer therapy-related cardiac dysfunction: a description of three cases.心脏磁共振成像与肌钙蛋白联合应用以促进癌症治疗相关心脏功能障碍的最早可逆转阶段的诊断和干预：三例病例描述
Quant Imaging Med Surg. 2024 Oct 1;14(10):7717-7722. doi: 10.21037/qims-24-910. Epub 2024 Sep 13.
2
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity.心脏关怀试验的原理和设计：一种基于肌钙蛋白指导的神经激素阻断预防蒽环类药物心脏毒性的随机试验。
Circ Heart Fail. 2022 Jul;15(7):e009445. doi: 10.1161/CIRCHEARTFAILURE.121.009445. Epub 2022 Jun 29.
3
A colossal, enigmatic, and long-lasting high-sensitivity cardiac troponin T elevation.肌钙蛋白 T 高敏检测呈巨量、神秘且持久升高。
Clin Chim Acta. 2021 Sep;520:214-216. doi: 10.1016/j.cca.2021.06.018. Epub 2021 Jun 11.
4
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.多中心、前瞻性、随机对照试验：高敏心肌肌钙蛋白 I 指导下的血管紧张素受体阻滞剂联合β受体阻滞剂治疗预防蒽环类药物心脏毒性：心脏 CARE 试验。
Circulation. 2023 Nov 21;148(21):1680-1690. doi: 10.1161/CIRCULATIONAHA.123.064274. Epub 2023 Sep 25.
5
Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries.在肌钙蛋白升高、急性胸痛综合征和无阻塞性冠状动脉疾病患者中，心脏磁共振成像的诊断贡献。
Arch Cardiovasc Dis. 2011 Mar;104(3):161-70. doi: 10.1016/j.acvd.2011.01.005. Epub 2011 Apr 2.
6
Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.在冠状动脉旁路移植术后，经心脏磁共振评估无确诊心肌梗死情况下心肌坏死生物标志物的异常升高。
J Cardiothorac Surg. 2017 Dec 29;12(1):122. doi: 10.1186/s13019-017-0684-3.
7
How is cardiac troponin released from injured myocardium?心肌损伤时肌钙蛋白如何释放？
Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):553-560. doi: 10.1177/2048872617748553. Epub 2017 Dec 27.
8
Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage.利用肌钙蛋白峰值区分心肌梗死与蛛网膜下腔出血性动脉瘤相关的可逆性神经源性左心室功能障碍。
J Neurosurg. 2003 Mar;98(3):524-8. doi: 10.3171/jns.2003.98.3.0524.
9
Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.蒽环类药物治疗与心肌细胞萎缩和心脏病的临床前表现有关。
JACC Cardiovasc Imaging. 2018 Aug;11(8):1045-1055. doi: 10.1016/j.jcmg.2018.05.012.
本文引用的文献
1
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction.欧洲心脏病学会心脏肿瘤学指南生物标志物标准对癌症治疗相关心脏功能障碍发生率的影响
JACC CardioOncol. 2024 Jan 16;6(1):83-95. doi: 10.1016/j.jaccao.2023.10.008. eCollection 2024 Feb.
2
The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity.先进心血管成像模式在心脏肿瘤学中的作用：从早期检测到阐明心脏毒性机制
J Clin Med. 2023 Jul 27;12(15):4945. doi: 10.3390/jcm12154945.
3
Advances in immune checkpoint inhibitors induced-cardiotoxicity.免疫检查点抑制剂诱导的心脏毒性的研究进展。
Front Immunol. 2023 Feb 23;14:1130438. doi: 10.3389/fimmu.2023.1130438. eCollection 2023.
4
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
5
Clinical Practice Guidelines in Cardio-Oncology.心血管肿瘤学临床实践指南。
Heart Fail Clin. 2022 Jul;18(3):489-501. doi: 10.1016/j.hfc.2022.02.002. Epub 2022 Jun 1.
6
Role of Myocardial Strain Imaging in Cancer Therapy-Related Cardiac Dysfunction.心肌应变成像在癌症治疗相关心功能障碍中的作用。
Curr Cardiol Rep. 2022 Jun;24(6):739-748. doi: 10.1007/s11886-022-01692-7. Epub 2022 May 6.
7
Cardiac MRI Depicts Immune Checkpoint Inhibitor-induced Myocarditis: A Prospective Study.心脏 MRI 描绘免疫检查点抑制剂所致心肌炎：一项前瞻性研究。
Radiology. 2021 Dec;301(3):602-609. doi: 10.1148/radiol.2021210814. Epub 2021 Sep 28.
8
Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.超高场心血管磁共振 T1 和 T2 mapping 用于评估大鼠模型中蒽环类药物诱导的心脏毒性：与组织病理学变化的对比验证。
J Cardiovasc Magn Reson. 2021 Jun 17;23(1):76. doi: 10.1186/s12968-021-00767-8.
9
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.癌症患者在肿瘤治疗全程中心血管疾病的管理：ESMO 共识推荐。
Ann Oncol. 2020 Feb;31(2):171-190. doi: 10.1016/j.annonc.2019.10.023.
10
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关致死性心肌炎报告增加。
Lancet. 2018 Mar 10;391(10124):933. doi: 10.1016/S0140-6736(18)30533-6.
Zotero 插件